Three novel compounds, named the aselacins, which inhibit the binding of endothelin to its receptor have been isolated from two related Acremonium species of fungi grown in stationary culture. These compounds are cyclic pentapeptolides with a ring formed by cyclo[Gly-D-Ser-D-Trp-/?-Ala-L-Thr] and an additional exocyclic D-Gln to which is attached a functionalized long chain fatty acid. The aselacins differ in the functionalization of this acid. The structures of the aselacins weredetermined by amino acid analysis, mass spectrometry and evaluation of 1-D and 2-D homonuclear and heteronuclear^H, 13C and 15N NMRspectra in protic and aprotic solvents. The stereochemistry of the amino acids present was elucidated by chiral HPLCof hydrolyzed compound.
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In the course of screening for compounds which inhibit binding of endothelin to its receptor, three novel cyclic pentapeptolides have been isolated from the fungi AB 2093T-194 and AB 2086L-51 grown in stationary culture. A companion paper1} describes the taxonomy and growth of the producing culture as well as the biological evaluation of the aselacins (1~3). This paper will discuss the isolation of aselacin A, B and C and the elucidation of their structures. Isolation of Aselacins A and B As described in the preceding paper1}, the fungus AB2093T-194 was grown in stationary culture. After 21 days of growth in four, 20 liters carboys (the four containing a total of 5.6 liters of liquid medium on 2.4 kg of shredded wheat), acetone (1.2 liters) was added to the fungal mass and media and the mixture was allowed to sit at room temperature for six hours after which a mixture oftoluene -ethyl acetate (0.75 liters of each) was added and the mixture was left overnight at 4°C. Solvent was then removed from the solid mass and concentrated to a brownoil. This oil was partitioned between heptane -methanol -water -acetic acid (5liters:3liters:2liters:0.02liter) and the lower layer was concentrated to an oil. This oil was triturated sequentially with heptane, ethyl acetate, ethanol and methanol (2 liters of each). The ethanol soluble material was chromatographed on a Sephadex LH-20column developed in methanol. The ability of fractions to displace radioactive endothelin from tissue preparations was assayed as described1}. Active fractions from the LH-20column were combined, concentrated to dryness and subjected to countercurrent chromatographyon an Ito multi-layered coil planet centrifuge in a solvent system ofethyl acetate -ethanolwater (2 : 1 : 2) with the lower phase stationary. Active fractions from this column were combined based upon their behavior on thin layer chromatography (TLC) and dried to yield pure aselacin A (1, 241 mg) and a clear oil of mixed components. This oil was subjected to countercurrent chromatography on an Ito multi-layered coil planet centrifuge in a solvent system of chloroform-methanol -water (1 : 1 : 1) with the lower phase stationary. Active fractions from this column were combined based upon their TLCbehavior to yield pure aselacin A (9mg) and pure aselacin B (3mg). (See Fig. 1 for a schematic of this isolation.)
Isolation of Aselacin C The fungus AB2086L-51 was grown and extracted in a manner identical to that described above for the fungus AB2093T-194. Initial work-up procedures, including the partition and extraction were also identical. The ethanol solubles from the partition were chromatographed on a Sephadex LH-20column developed in ethanol. Active fractions from the LH-20 column were combined, concentrated to dryness and rechromatographed over a Sephadex LH-20 column developed with methanol -ethyl acetate (1 : 1). Active fractions from this columnwere combinedand concentrated to a clear oil. This oil was subjected to countercurrent chromatographyon an Ito multi-layered coil planet centrifuge in a solvent system of chloroform -methanol -water (1 : 1 : 1) with the lower phase stationary. Active fractions from this column were combined to yield pure aselacin C (8mg). (See Fig. 1 for a schematic of this isolation.)
Structure Determination of the Aselacins Structure Determination of Aselacin A NMRspectral analysis of aselacin A (1) suggested the presence of amino acid residues, and this was confirmed by an amino acid analysis which indicated the presence of tryptophan, threonine, serine, glycine, jS-alanine and either glutamic acid or glutamine moieties. A failed Edmandegradation suggested that there Table 1 ). See experimental for description of conditions A and Bold peaks were those enhanced by co-injection.
These results indicated that aselacin
of aselacin A as outlined in Table 2 . Carbon signal assignments were made for these same amino acids with an HMBC2) and an HMQC3) experiment and are outlined in Table 3 . The HMBC experiment allowed the assignment of a pentapeptolide ring comprised of the amino acids cyclo[Gly-D-Ser-D-Trp-/?-Ala-L-Thr] with a peptolide linkage through D-Thr by the analysis of long range heteronuclear couplings as follows; the carbonyl carbon signal of serine (d 173.6) was coupled to the serine a and ft proton signals at S 4.08, 3.83 and 3.50 and to the a protons of glycine at S 4.05 and 3.59; the carbonyl carbon signal of tryptophan (S 174.5) was coupled to the tryptophan a Ser-a CH Ser-P CH2 
Trp-C-7 Trp-C-7â -Ala-CO P-Alsi-a CH2
p-Ala-P CH2 and P proton signals at 5 4.76, 3.27 and 3.18 and to the a proton of serine at d 4.08; the carbonyl carbon signal of /?-alanine (S 174.5) was coupled to the jS-alanine a and p proton signals at 5 2.89, 2.41, 3.71 and 3.13 and to the a proton oftryptophan at S 4.76; the carbonyl carbon signal of threonine (d 170.8) was coupled to the threonine a and p proton signals at S 4.63 and 5.59 (the chemical shift of which clearly indicates an ester linkage) and to the p protons of jS-alanine at 5 3.71 and 3.13; the carbonyl carbon signal of glycine (S 169.8) was coupled to the glycine a-proton signals at S 4.05 and 3.59 and to the j5 proton of threonine at S 5.59. Threonine must therefore be attached through its jS carbon to glycine thus forming a peptolide ring.
Further long range couplings were observed between the carbonyl carbon signal of glutamine (S 176.0) and its a and /? proton signals at S 4.16, 1.92 and 1.84 and to the fi proton signal ofthreonine thus indicating that glutamine was exocyclic to the pentapeptolide previously described. This residue was determined to be a glutamine (rather than glutamic acid) with substitution on the a amino group and unsubstituted at the £-carboxyamide by acquiring in DMSO-d6;a 15N NMRspectrum and DEPT, â -^N HMQC and a *H COSYspectrum which allowed the assignment of all proton and nitrogen signals (see Table 4 A fast atom bombardmentpositive ion mass spectrum of aselacin A gave a molecular ion of m/z 909 (M+H) for a molecular formula encompassing the six previously discussed amino acids plus an additional C18H31O. Remaining carbon signals in the 13C NMRspectrum (see Table 3 ) included those for one amide, two disubstituted oleflns, one oxygensubstituted methine, one methyl and 1 1 methylenes. A COSYexperiment allowed assignment to these signals of an 18-carbon fatty acid with a diene at C-10~C-13 and an hydroxyl at C-9. Electrospray MS-MSindicated that this fatty acid is attached to the exocyclic glutamine as evidenced by a major fragmentation peak at m/z 503 for the cyclopentapeptolide with concomitant loss of glutamine and the fatty acid. This attachment is further supported by a ROESY4) experiment in DMSO-J6in which a nuclear Overhauser effect (NOE) is observed between the a amine proton (3 8.41) of glutamine and the C-2 methylene protons (3 2.19) of the fatty acid.
Structure Determination of Aselacin B A fast atom bombardment positive ion mass spectrum of aselacin B gave a molecular ion of m/z 923 (M+H)which was 14 mass units higher than that for aselacin A. Homonuclear and heteronuclear 1-D and 2-D experiments indicated that the amino acid portion of aselacin B was identical to that for aselacin A (see Tables 2 and 3 ). Thus the aselacins differed from one another solely in the fatty acid side chain attached to each of their glutamine residues. The 13C NMRspectrum (see Table 3 ) of aselacin B contained a signal at 3 203.8 indicating the presence of a ketone functionality. An HMBC experiment showed long range coupling between this ketone and a diene olefinic system with proton signals at 3 6.06 (C-10), 7.18 (C-ll), 6.26 (C-12) and 6.24 (C-13) for an ap, y<5-unsaturated ketone.
Aselacin B contained an hydroxymethine with a carbon signal at 3 68.3 (C-17) and a proton at 3 3.72 which were not present in aselacin A. The 3 3.72 (C-17) proton signal was coupled to a methyl doublet signal at 3 1.14 indicating that oxidation has occured at the C-17 position of the fatty acid chain in aselacin B relative to that of aselacin A. A COSYexperiment showed further coupling from the 3 3.72 proton signal to methylene proton signal at 3 1.49 (C-16) which was also coupled to a methylene proton signal at 3 1.53 (C-15) which was also coupled to a methylene proton signal at 3 2.23 (C-14) which coupled into the 3 proton of the oc/3, y<5-unsaturated ketone group thus placing that functionality at carbons 9~13 of the octadecanoic acid side chain.
Structure Determination of Aselacin C A fast atom bombardmentpositive ion mass spectrum of aselacin C gave a molecular ion of mjz 907 (M + H) which was 2 mass units lower than that for aselacin A. Homonuclear and heteronuclear 1-D and 2-D experiments indicated that the amino acid portion of aselacin C was identical to that for aselacin A (see Tables 2 and 3) . Aselacins A and C therefore differed in their fatty acid side chains. The 13C NMR spectrum (see Table 3 ) of aselacin C contained a signal at S 203.9 indicating the presence of a ketone functionality. An HMBC experiment showed long range coupling between this ketone and a diene olefinic system with proton signals at S 6.06 (C-10), 7.18 (C-ll), 6.20 (C-12) and 6.24 (C-13) for an ap,y5-unsaturated ketone comparable to that present in the structure of aselacin B. The remainder of the fatty
